P

Inventor

WEINSTEIN DAVID S

US36 patents
⚠️ This page may combine multiple inventors who share the name “WEINSTEIN DAVID S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BRISTOL MYERS SQUIBB CO

35 patents
US9505748B2Nov 29, 2016

Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFNα responses

BRISTOL MYERS SQUIBB CO53 citations97
US6887870B1May 3, 2005

Heterocyclic sodium/proton exchange inhibitors and method

BRISTOL MYERS SQUIBB CO51 citations95
USRE47929EApr 7, 2020

Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFNα responses

BRISTOL MYERS SQUIBB CO19 citations94
US10000480B2Jun 19, 2018

Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses

BRISTOL MYERS SQUIBB CO20 citations94
US9663467B2May 30, 2017

Alkyl-amide-substituted pyridyl compounds useful as modulators of IL-12, IL-23 and/or IFNα responses

BRISTOL MYERS SQUIBB CO21 citations93
US7326705B2Feb 5, 2008

Heterocyclic sodium/proton exchange inhibitors and method

BRISTOL MYERS SQUIBB CO24 citations92
US11021475B2Jun 1, 2021

Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses

BRISTOL MYERS SQUIBB CO8 citations84
US11021462B2Jun 1, 2021

Sulfone pyridine alkyl amide-substituted heteroaryl compounds

BRISTOL MYERS SQUIBB CO6 citations84
US9540333B2Jan 10, 2017

Alkyl amide-substituted pyrimidine compounds useful in the modulation of IL-12, IL-23 and/or IFNα

BRISTOL MYERS SQUIBB CO11 citations84
US9987266B2Jun 5, 2018

Alkyl-amide-substituted pyridyl compounds useful as modulators of IL-12, IL-23 and/or IFNα responses

BRISTOL MYERS SQUIBB CO9 citations83
US9315494B2Apr 19, 2016

Alkyl-amide-substituted pyridyl compounds useful as modulators of IL-12, IL-23 and/or IFNα responses

BRISTOL MYERS SQUIBB CO14 citations83
US11787779B2Oct 17, 2023

Sulfone pyridine alkyl amide-substituted heteroaryl compounds

BRISTOL MYERS SQUIBB CO2 citations73
US10294256B2May 21, 2019

Phosphine oxide alkyl amide substituted heteroaryl compounds as modulators of IL-12, IL-23 and/or IFN alpha responses

BRISTOL MYERS SQUIBB CO5 citations73
US10273237B2Apr 30, 2019

Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or IFN-α responses

BRISTOL MYERS SQUIBB CO4 citations73
US7253283B2Aug 7, 2007

Tricyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof

BRISTOL MYERS SQUIBB CO6 citations73
US7351727B2Apr 1, 2008

Inhibitors of 15-lipoxygenase

BRISTOL MYERS SQUIBB CO4 citations63
US12365667B2Jul 22, 2025

Sulfone pyridine alkyl amide-substituted heteroaryl compounds

BRISTOL MYERS SQUIBB CO0 citations62
US8034940B2Oct 11, 2011

Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof

BRISTOL MYERS SQUIBB CO4 citations62
US7888381B2Feb 15, 2011

Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity, and use thereof

BRISTOL MYERS SQUIBB CO6 citations62
US11597721B2Mar 7, 2023

Heterocyclic compounds comprising pyridine useful as modulators of IL-12, IL-23 and/or IFNα responses

BRISTOL MYERS SQUIBB CO1 citations59
US10479793B2Nov 19, 2019

Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses

BRISTOL MYERS SQUIBB CO1 citations59
US12528782B2Jan 20, 2026

Prodrugs in the modulation of interleukin

BRISTOL MYERS SQUIBB CO0 citations56
US12479831B2Nov 25, 2025

Substituted N(-methyl-D3)pyridazine-3-carboxamide or M-(methyl-D3)-nicotinamide compounds as IL-12, IL-23 and/or IFNα modulators

BRISTOL MYERS SQUIBB CO0 citations52
US11299494B2Apr 12, 2022

Substituted imidazo[1,2-b]pyridazines as interleukin-23 and interferon-α modulators

BRISTOL MYERS SQUIBB CO0 citations52
US10781215B2Sep 22, 2020

Heterobicyclic compounds useful as modulators of IL-12, IL-23 and/or IFNα responses

BRISTOL MYERS SQUIBB CO0 citations52
US7534804B2May 19, 2009

Benzoxazole inhibitors of 15-lipoxygenase

BRISTOL MYERS SQUIBB CO0 citations52
US7432271B2Oct 7, 2008

Pyrazolyl inhibitors of 15-lipoxygenase

BRISTOL MYERS SQUIBB CO1 citations52
US7544808B2Jun 9, 2009

Tricyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof

BRISTOL MYERS SQUIBB CO0 citations51
US9796720B2Oct 24, 2017

Imidazole-derived modulators of the glucocorticoid receptor

BRISTOL MYERS SQUIBB CO0 citations41
US9725443B2Aug 8, 2017

RORγ modulators

BRISTOL MYERS SQUIBB CO0 citations41
US9663469B2May 30, 2017

RORγ modulators

BRISTOL MYERS SQUIBB CO0 citations41
US9593113B2Mar 14, 2017

Imide and acylurea derivatives as modulators of the glucocorticoid receptor

BRISTOL MYERS SQUIBB CO0 citations41
US7317032B2Jan 8, 2008

Imidazolyl inhibitors of 15-lipoxygenase

BRISTOL MYERS SQUIBB CO0 citations41
US7605264B2Oct 20, 2009

Heterocyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof

BRISTOL MYERS SQUIBB CO0 citations40
US7429611B2Sep 30, 2008

Indole inhibitors of 15-lipoxygenase

BRISTOL MYERS SQUIBB CO0 citations40

DUAN JINGWU

1 patent